#USA #Boston #Drug Discovery #Ginkgo Bioworks #ADME Service

Ginkgo Bioworks Launches Advanced ADME Profiling Service

Ginkgo Bioworks, known for pioneering advancements in cell programming and biosecurity, recently announced the introduction of a revolutionary ADME (Absorption, Distribution, Metabolism, and Excretion) profiling service. This new offering has the potential to significantly accelerate the drug discovery process, enabling researchers to efficiently evaluate small molecules and make informed decisions earlier in the development pipeline.

Enhanced Automation for Efficiency

The new ADME profiling service utilizes Ginkgo's proprietary RAC automation technology, which facilitates high-throughput and cost-effective workflows. The company is not only committed to maintaining high standards of quality but also promises pricing that will compete with, or even beat, quotes from international vendors, particularly those in China. This strategic move is designed to enhance the accessibility of advanced biopharma services and support US-based operations.

CEO Jason Kelly expressed excitement about the launch, emphasizing Ginkgo's belief in providing world-class services at competitive prices. With the capability to match existing quotes, and optimism about surpassing competitors on individual project pricing, Ginkgo Bioworks is poised to become a significant player in the biopharmaceutical sector. Kelly stated, "We will price match any ADME service quote you get, including from Chinese or other international vendors, though we hope to beat them on per-compound pricing out of the gate."

Key Features of the Service

This newly launched ADME profiling service is characterized by several key features:
1. Scalable Workflow: Ginkgo’s automation ensures that workflows are streamlined and can handle substantial throughput, crucial for meeting the demands of modern drug discovery.
2. Affordable Pricing Model: With a commitment to cost-effectiveness, Ginkgo's pricing structure has been designed to compete with international labs without compromising quality.
3. Rapid Turnaround Time: In an industry where speed is crucial, Ginkgo's processes are built to align with fast-paced discovery timelines, ensuring quick access to essential data.
4. Model-Ready Datasets: Researchers will benefit from rich datasets enhanced with structured metadata, facilitating seamless integration into AI-powered applications.

Revolutionizing Drug Development

Ginkgo Bioworks aims to transform the drug development landscape with this service. By providing early and rich access to key ADME data, the company empowers scientists to prioritize candidates effectively and train predictive models at an unparalleled speed. The integration of AI-compatible outputs marks a significant shift from traditional methods that often result in fragmented data and inefficiencies.

The ambition is clear: to advance biopharma research by delivering clean, actionable data at library scale. This unified approach to biological data will enable a more robust and algorithm-friendly interface for researchers, decreasing the time spent on data collection and increasing focus on innovation and discovery.

About Ginkgo Bioworks

Ginkgo Bioworks continues to establish itself as a leader in synthetic biology, providing revolutionary tools that simplify the engineering of biological systems. In addition to its new ADME profiling service, Ginkgo Automation offers integrated laboratory automation solutions, allowing scientists to focus more on analysis and innovation rather than routine laboratory tasks. With Ginkgo Datapoints, researchers gain access to vast data sets generated through in-house automation, fueling advancements in AI applications in the life sciences realm.

For more information on Ginkgo's innovation and offerings, visit ginkgobioworks.com. You can also follow the company on platforms like X, Instagram, Threads, and LinkedIn for updates and insights on their latest advancements in biotechnology and biosecurity.